TrialPharmacology research & perspectives2020

Immunogenicity and safety of a proposed pegfilgrastim biosimilar MSB11455 versus the reference pegfilgrastim Neulasta

Chris Wynne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.